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Endochondral  ossiﬁcation,  the  mechanism  responsible  for the  development  of  the  long  bones,  is  depen-
dent  on  an extremely  stringent  coordination  between  the processes  of chondrocyte  maturation  in the
growth  plate,  vascular  expansion  in the  surrounding  tissues,  and  osteoblast  differentiation  and  osteo-
genesis  in  the  perichondrium  and  the  developing  bone  center.  The  synchronization  of these  processes
occurring  in  adjacent  tissues  is  regulated  through  vigorous  crosstalk  between  chondrocytes,  endothelial
cells  and osteoblast  lineage  cells.  Our knowledge  about  the  molecular  constituents  of  these  bidirec-
tional  communications  is  undoubtedly  incomplete,  but certainly  some  signaling  pathways  effective  in
cartilage  have  been  recognized  to  play  key  roles  in steering  vascularization  and  osteogenesis  in  the  peri-
chondrial tissues.  These  include  hypoxia-driven  signaling  pathways,  governed  by the  hypoxia-inducible
factors  (HIFs)  and  vascular  endothelial  growth  factor  (VEGF),  which  are  absolutely  essential  for  the  sur-
vival and  functioning  of  chondrocytes  in  the avascular  growth  plate,  at least  in part by regulating  the
oxygenation  of developing  cartilage  through  the  stimulation  of  angiogenesis  in  the  surrounding  tissues.
A  second  coordinating  signal  emanating  from  cartilage  and  regulating  developmental  processes  in the
adjacent  perichondrium  is  Indian  Hedgehog  (IHH).  IHH,  produced  by  pre-hypertrophic  and  early  hyper-HH
trophic  chondrocytes  in the growth  plate,  induces  the differentiation  of  adjacent  perichondrial  progenitor
cells  into  osteoblasts,  thereby  harmonizing  the site  and time  of  bone  formation  with  the developmental
progression  of chondrogenesis.  Both  signaling  pathways  represent  vital  mediators  of  the  tightly  orga-
nized  conversion  of  avascular  cartilage  into  vascularized  and  mineralized  bone  during endochondral
ossiﬁcation.
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. Introduction
All the long bones of the mammalian skeleton originate from
artilage templates via a complex multistep process termed endo-
hondral ossiﬁcation. During this process, mineralized bone is
ormed through the deposition of bone matrix by differentiated
steoblasts on top of a scaffolding cartilage mold generated by
hondrocytes. This mold or cartilaginous bone template is formed
uring early fetal limb development by cells within the mesenchy-
al  condensations that commit to the chondrocyte lineage under
he inﬂuence of SOX9, the master transcriptional regulator of chon-
rogenesis [1]. Adequate longitudinal growth of the endochondral
ones is absolutely dependent on precisely regulated proliferation,
ifferentiation and matrix production by chondrocytes in the car-
ilaginous condensations and later in the growth plate. In addition,
roper progression of bone development relies on a very stringent
oordination between the processes of chondrocyte maturation
n the growth plate, vascular expansion in the surrounding tis-
ues, and osteoblast differentiation, recruitment, and bone-forming
ctivity in the perichondrium and the developing bone center.
he synchronization of these processes occurring in these adjacent
issues is regulated through vigorous crosstalk between chondro-
ytes, endothelial cells and osteoblast lineage cells. Studies using a
rowing number of genetically modiﬁed mouse models are increas-
ngly providing insights in the molecular interplay regulating these
omplex interactions, some of which will be reviewed here (Fig. 1).
. Chondrocyte-driven regulation of angiogenesis in
urrounding tissues
During endochondral ossiﬁcation, chondrocytes ﬁrst generate
artilaginous templates of the forming bones from mesenchymal
ondensations, and subsequently create the growth plates that
rovide the prime engine for bone growth. These cartilaginous
tructures are rather unique tissues in that they are inherently
vascular and physiologically hypoxic [2–4]. Hypoxia-driven path-
ays, governed by transcription factors called hypoxia-inducible
actors (HIFs), are absolutely essential for the survival and func-
ioning of chondrocytes in these challenging conditions [4] (see
ig. 2). HIF-mediated signaling has also been implicated in joint for-
ation and the integrity of the adult articular cartilage [5,6]. One
f the mechanisms by which HIF supports cartilage developmentPlease cite this article in press as: C. Maes, Signaling pathw
sues. Seminars in cell and developmental biology: The biology
http://dx.doi.org/10.1016/j.semcdb.2016.05.007
s through the regulation of angiogenesis in the adjacent perichon-
rial tissues, mediated by the potent angiogenic stimulator vascular
ndothelial growth factor (VEGF) that is a direct transcriptional
arget of HIF (see Fig. 2). VEGF is also a key driver of the progres- . . . .  . .  .  .  . . .  . .  .  . . . . . . .  . . . . .  . . .  . .  . . . . . .  . .  .  . . .  .  .  . .  . . .  .  .  .  . .  .  .  .  .  . . . .  . . . . .  .  . .  .  .  .  . .  00
sive conversion of the preﬁguring cartilage into bone tissue during
skeletal development and growth, a process that is driven by car-
tilage neovascularization and the concomitant inﬁltration of the
future ossiﬁed region by osteoprogenitors (see Fig. 3). Here, we will
go deeper into the studies performed to dissect the roles of hypoxia
pathway components and VEGF family members during these key
stages of the endochondral ossiﬁcation program.
2.1. The multiple roles of the hypoxia-HIF-VEGF network in
avascular cartilage
2.1.1. Hypoxia-inducible factors (HIFs)
Cartilage, being an intrinsically avascular tissue, is highly
dependent on cellular hypoxia-adaptation mechanisms. HIFs, the
transcription factors that are the main orchestrators of the cel-
lular responses to hypoxia, act as heterodimers consisting of an
-subunit which is regulated by oxygen (HIF-1,  HIF-2/EPAS1,
or the less characterized HIF-3), and a  subunit that is consti-
tutively expressed in an oxygen-independent manner. The best
characterized member, HIF-1, is formed in hypoxic conditions by
the subunits HIF-1  and HIF-1  (also known as aryl hydrocar-
bon receptor nuclear translocator (ARNT)), which both contain
basic helix-loop-helix-PAS domains that mediate heterodimeriza-
tion and DNA binding [7–9].
In well-oxygenated conditions, the HIF-1 protein is hydroxy-
lated on speciﬁc residues within its amino-acid sequence (prolines
P402 and P564 in the oxygen-dependent degradation domain
(ODD)), in an oxygen-dependent reaction executed by HIF prolyl-
hydroxylase enzymes (PHD1-3, also known as Egln2, 1, and 3) [10].
Hydroxylated HIF-1 is recognized by the Von Hippel-Lindau pro-
tein (pVHL), which is part of an E3 ubiquitin ligase complex, leading
to the ubiquitination and instant proteosomal degradation of HIF-
1 in non-hypoxic conditions [7–9].
In hypoxia, represented by oxygen tension levels dropping
below an estimated threshold of 5%, the hydroxylation and degra-
dation of HIF-1 is inhibited. As HIF-1 is stabilized in these
conditions, the protein can translocate to the nucleus and dimerize
with HIF-1.  Along with nuclear co-factors such as p300 and CREB-
binding protein (CBP), HIF-1 and HIF-1  form the transcriptional
complex HIF-1. The complex can bind to hypoxia responsive ele-
ments (HRE), present in the promoter region of target genes, and
induce transcription. More than a hundred putative HIF-1 targetays effecting crosstalk between cartilage and adjacent tis-
 and pathology of cartilage, Semin Cell Dev Biol (2016),
genes have been identiﬁed, several of which function in cell pro-
liferation, differentiation, survival, resistance to oxidative stress,
apoptosis, and extracellular matrix homeostasis, but most typically
and abundantly involving genes regulating energy metabolism and
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Fig. 1. Crosstalk between cartilage and adjacent tissues, focusing on chondrocyte-derived factors regulating angiogenesis and osteogenesis in the surrounding perichondrium
and  bone center. Abundant crosstalk and interplay between chondrocytes, endothelial cells, and osteoblasts ensures the proper synchronization of endochondral bone
development and growth. VEGF and IHH represent two  key cartilage-derived signaling molecules serving critical coordinating roles in endochondral ossiﬁcation by inducing
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ingiogenesis and osteogenesis in the tissues surrounding the avascular cartilage. Co
actors,  respectively, which in addition to regulating angiogenic-osteogenic coupl
onstituents that mediate this reciprocal communication are only beginning to be u
ngiogenesis [7–9]. Indeed, the major overall goal of the hypoxia-
esponse is increasing the oxygen delivery to hypoxic tissues while
ecreasing their oxygen consumption. HIFs hereby function as
aster regulators of oxygen homeostasis through their combined
ranscriptional actions on VEGF, stimulating angiogenesis, erythro-
oietin (EPO), activating erythropoiesis, and glycolytic enzymes
nvolved in anaerobic metabolism. The latter mediate the cell’s
daptation to hypoxia by reducing its oxygen consumption in
lucose utilization pathways and its dependence on oxygen to
enerate ATP. The shift towards glycolysis at the same time pre-
ents the generation of excess reactive oxygen species (ROS) in the
itochondria due to inefﬁcient electron transport under hypoxic
onditions [7–9].
.1.2. Hypoxia-driven, VEGF-mediated angiogenesis in
artilage-surrounding tissues
A myriad of mouse genetics studies performed over the past 15
ears support the essential roles of HIF-1 and VEGF in chondro-
yte biology and the regulation of the development and growth of
he long bones. Given the early fetal lethality of ubiquitous knock-
ut mice for these important molecules, insights in skeletal biology
ave been gained predominantly by employing selective knock-
n mice and Cre-loxP strategies to generate conditional knockout
cKO) models. Particularly the use of the Prx1-Cre- and type II col-
agen (Col2)-Cre driver strains, targeting respectively the fetal limb
ud mesenchyme or endochondral osteochondroprogenitors and
hondrocytes, has been instrumental in deﬁning the functions of
he hypoxia-regulated pathways and speciﬁc molecular compo-
ents thereof in endochondral bone development.
The ﬁrst study that revealed the essential physiological role
f hypoxia-driven pathways in cartilage used a Col2-Cre driven
onditional deletion model of HIF-1, showing that loss of HIF-
 in chondrocytes led to massive cell death in the developingPlease cite this article in press as: C. Maes, Signaling pathwa
sues. Seminars in cell and developmental biology: The biology
http://dx.doi.org/10.1016/j.semcdb.2016.05.007
rowth plate, resulting in dwarﬁsm with marked shortening of the
imbs [4]. Speciﬁcally, the chondrocytes located in the center of the
rowth cartilage, farthest from the perichondrial blood vessels, died
n the absence of HIF-1.  These regions co-localized with the pres-ely, endothelial cells and osteoblast lineage cells release angiocrine and osteocrine
ay  also affect the differentiation or fate of adjacent chondrocytes. The molecular
led.
ence of hypoxia, as detected by a marker for bioreductive activity
(EF5) [4]. Since this pioneering work, several studies have increas-
ingly shed light on the mechanisms by which HIF-1 ensures the
survival of hypoxic chondrocytes, including the direct activation
of genes that enable chondrocytes to switch to oxygen-sparing
metabolic pathways (see further) and the indirect consequences
of induction of VEGF [2,11] (Fig. 2).
VEGF is one of the most powerful and critical mediators of angio-
genesis. The deletion of even a single copy of the VEGF gene resulted
in early embryonic lethality due to defective vascular development
[12,13]. Interestingly, mutant mice in which VEGF was deleted in
cartilage showed massive apoptosis of non-hypertrophic, hypoxic
chondrocytes in the interior of the developing growth plate
[2,14,15], similar to what was seen with HIF-1 deﬁciency [4]. Since
the expression and protein stability of VEGF is regulated by hypoxia
at multiple levels, including a direct transcriptional activation by
HIF-1 [16–19], these ﬁndings suggested that VEGF is downstream
of HIF-1  and that the hypoxia-HIF-VEGF network provides a vital
pathway supporting chondrocyte survival in the avascular growth
plate during bone development.
Several observations indicate that the prime function of
cartilage-derived VEGF is to stimulate angiogenesis in the imme-
diate surrounding perichondrial tissues, thereby increasing the
oxygen supply into the growing cartilage and lessening the degree
of hypoxia to prevent cell death (Fig. 2). Indeed, mice lacking
VEGF in cartilage (Col2-Cre driven) displayed impaired vascular-
ization surrounding the epiphysis and increased hypoxia within
the cartilage [2]. These phenotypic manifestations, as well as the
aberrant apoptosis of centrally located chondrocytes, could be
rescued completely by transgenic over-expression of VEGF164 in
the Col2-expressing cells, which induced excessive perichondrial
angiogenesis [2]. VEGF164 is one of the major splice isoforms of
VEGF, which are derived from a single VEGF gene through alter-ys effecting crosstalk between cartilage and adjacent tis-
 and pathology of cartilage, Semin Cell Dev Biol (2016),
native splicing of the pre-mRNA. Five VEGF isoforms have been
identiﬁed in humans, while there are three major isoforms in
the mouse: VEGF120, VEGF164, and VEGF188. The shortest iso-
form, VEGF120, lacks the basic, heparin-binding residues encoded
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Fig. 2. The role of the HIF—VEGF network in developing cartilage. (Left) Hypoxia-driven, VEGF-mediated angiogenesis in cartilage-surrounding tissues. Avascular cartilage
exists  as a physiological hypoxic tissue during bone development and growth. A gradient of reducing oxygenation emanates from the vascularized peripheral tissues towards
the  interior of the growth plate, which inherently becomes hypoxic as the cartilage element grows (blue area). Hypoxia, at least in part via HIF-1, induces expression of
VEGF  by the chondrocytes. The soluble VEGF isoforms VEGF120 and VEGF164, but not the matrix-bound isoform VEGF188, can diffuse to the perichondrial tissues around the
cartilage  and stimulate angiogenesis, increasing the O2 supply into the cartilage and limiting the degree of hypoxia. HIF-1 additionally serves to switch the energy metabolism
of  the chondrocytes towards anaerobic glycolysis, consequentially reducing the use of oxygen. By controlling oxygen availability and consumption, the hypoxia-HIF-VEGF
network ensures the survival of the hypoxic chondrocytes in the avascular growth cartilage. At a later stage, hypertrophic chondrocytes appear within the epiphyseal
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ssiﬁcation center formation. (Right) Additional roles of hypoxia-driven pathways in
evelopment and cartilage matrix maturation at multiple steps, as indicated in the
y exons 6 and 7, whereas VEGF164 lacks the residues encoded
y exon 6. This confers upon the secreted proteins differences
n matrix binding, and is thought to create a gradient of VEGF
or directional recruitment or growth of endothelial cells during
ngiogenesis: VEGF188 is mostly sequestered in the matrix, from
here it can be released by proteases during matrix degradation,
hile VEGF120 fails to bind heparin and can diffuse to a more dis-
ant site. VEGF164 has intermediate matrix-association/solubility
roperties, and can furthermore bind the co-receptors neuropilin
NRP)-1 and NRP-2, in addition to the main receptor tyrosine
inases VEGFR-1 and VEGFR-2 [20,21]. These characteristics ren-
er this isoform particularly effectual, as knock-in mice in which
he endogenous 8-exon-comprising VEGF gene was replaced by the
DNA encoding only the VEGF164 isoform showed no noticeable
henotypic alterations [22–24], including normal development of
he endochondral bones [14]. In contrast, expression of exclusively
he matrix-binding VEGF188 isoform recapitulated the impaired
ascularization surrounding the epiphysis, aberrant hypoxia within
he cartilage, and central chondrocyte apoptosis phenotype of mice
onditionally lacking VEGF (all isoforms) or HIF-1 in cartilage [14],
hereas expression of only the freely soluble VEGF120 isoform did
ot [25]. These ﬁndings indicate that soluble VEGF isoforms are
ritically required to stimulate vascularization in the perichondrial
issues surrounding the avascular cartilage, presumably due to their
bility to diffuse to the surface of the cartilage. Thus, through the
xpression and secretion of hypoxia-induced VEGF, chondrocytes
nstruct the expansion of the epiphyseal vascular network in coor-
ination with the growth of the avascular cartilage mass, in order
o ensure sufﬁcient oxygen supply to support chondrocyte survival
Fig. 2).
Interestingly, also in the early skeletal patterning stages duringPlease cite this article in press as: C. Maes, Signaling pathw
sues. Seminars in cell and developmental biology: The biology
http://dx.doi.org/10.1016/j.semcdb.2016.05.007
mbryogenesis, VEGF secreted by the limb bud mesenchyme of the
orming cartilaginous condensations appeared to act via a long-
anging mechanism (without involvement of receptor signaling ins involved in attracting blood vessels into the epiphysis and launching secondary
age development. In the avascular cartilage, hypoxia and HIF-1 affect chondrocyte
e. For details, see text. Figure adapted from [21,177].
the condensations proper) to mediate the rearrangements in the
vascular plexus in the surrounding tissues [26,27].
Notably, over-expression of transgenic VEGF164 in cartilage
lacking HIF-1  could rescue vascularization in the surrounding
tissues, but failed to completely restore the oxygen levels in the car-
tilage and only partially prevented the cell death phenotype [2]. The
reason for this was  found in a second vital mechanism downstream
of HIF-1,  independent of VEGF, in the regulation of the metabolic
adaptation of the chondrocytes when they become hypoxic during
growth of the cartilaginous tissue mass. To support their survival,
HIF-1 is absolutely essential to reprogram energy metabolism
in the chondrocytes towards the use of oxygen-sparing anaerobic
pathways [2]. This is achieved through induction of the expression
of classical HIF target genes that mediate glycolysis, such as the
enzyme phosphoglycerate-kinase 1 (PGK1), or that impair mito-
chondrial respiration, such as pyruvate dehydrogenase kinase 1
(PDK1), which shunts pyruvate away from the mitochondrial tri-
carboxylic acid cycle [2,4,28]. These adaptations serve to limit the
oxygen consumption within cartilage.
Thus, HIF-1 regulates a ﬁne balance of oxygen delivery and
utilization in this challenged avascular tissue, to maintain the level
of hypoxia within the delicate optimal range for chondrocytes to
survive and develop and function normally [2] (Fig. 2).
2.1.3. Other roles of HIFs in chondrogenesis and cartilage
development
Besides its prime function in mediating chondrocyte survival
in their hypoxic environment, HIF-1  also regulates multiple other
aspects of chondrocyte biology in mesenchymal condensations and
developing growth plates (Fig. 2, right panel), as indicated by the
study of a number of mutant mouse models. For instance, loss ofays effecting crosstalk between cartilage and adjacent tis-
 and pathology of cartilage, Semin Cell Dev Biol (2016),
HIF-1 in the early limb bud mesenchyme (mediated via the use
of Prx1-Cre mice) did not seem to affect the initial formation of the
mesenchymal condensations, but delayed the speciﬁcation of the
joints, the differentiation of mesenchymal cells into chondrocytes,
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nd their terminal transition to hypertrophic chondrocytes [3,29].
 myriad of reports have substantiated that low oxygen tension
romotes differentiation of mesenchymal stem cells into chondro-
ytes in vitro [30–36]. Interestingly, HIF-1 can induce expression
f the master chondrogenic transcription factor SOX9, suggesting
hat the function of HIF-1  as an early differentiation factor in
hondrogenesis may  be mediated through SOX9 [29,37].
Some of the generated conditional knockout mice also indicated
hat HIF-1 negatively regulates the proliferation of chondrocytes
n the developing growth cartilage (Fig. 2). In cartilage lacking
IF-1 (Col2-Cre driven), the proliferation rate of the viable chon-
rocytes in the peripheral regions of the fetal growth plate was
trikingly increased [4]. Conversely, the chondrocyte proliferation
ate was markedly reduced in mice with conditional inactivation of
HL (the E3 ubiquitin ligase that targets HIF-1  and HIF-2 to the
roteasome for degradation and thus serves as a negative regulator
f HIF activity) in cartilage or limb buds, which was  associated with
n increase of the cyclin-dependent kinase inhibitor p57 mRNA.
he loss of VHL in chondrocytes in vivo thereby resulted in a pro-
ounced hypocellularity in the growth plates and the mutant mice
isplayed severe dwarﬁsm [38,39]. The inhibiting effect of HIF-1
n chondrocyte proliferation could further contribute to its actions
o lower the oxygen consumption in the hypoxic tissue.
Another emerging function of HIF signaling in cartilage is in
he control of the cartilaginous matrix accumulation and matu-
ation (Fig. 2). Loss of VHL in cartilage or in the mesenchymal
ells of the limb buds appeared to be associated with an increased
ccumulation of matrix in between the chondrocytes [38,39]. The
elationship between hypoxia sensing and extracellular matrix
ECM) accumulation in cartilage involves a role for HIF-1  in
mproving the efﬁciency of post-translational modiﬁcations of
ype II collagen. These post-translational modiﬁcations, required
or the acquisition of the mature triple helix collagen structure,
nclude critical hydroxylation reactions of proline residues in the
ollagen proteins, which are catalyzed by a family of collagen
rolyl-4-hydroxylases (cP4Hs, in particular cP4HaI and cP4HaII).
f note, these enzymes are distinct from the family of prolyl-
ydroxylases that hydroxylate HIFs (the PHDs, introduced above)
ut also function in an oxygen-dependent manner by using oxy-
en as a substrate for proline hydroxylation [40]. The expression of
P4Hs in chondrocytes is induced through HIF-1-dependent tran-
criptional stimulation [19,28,41]. This molecular link may  explain
he role of HIF-1 in facilitating the correct folding of the colla-
en proteins in the endoplasmic reticulum (ER) and preventing ER
tress, and in increasing the secretion and accumulation of mature
ype II collagen in the cartilage ECM [16,28,38]. Moreover, accu-
ulation of inappropriately processed collagen in the absence of
IF-1 could trigger the unfolded protein response (UPR), lead to
R stress and cause cell death, suggesting that hypoxia-induced
P4H-activity may  contribute to the chondrocyte survival func-
ion of HIF-1 [28]. Recent evidence seems to support this idea,
s growth plates from mice with an almost 70% decrease of cP4Hs
nzymatic activity displayed an inner cell death phenotype rem-
niscent of that observed in growth plates lacking HIF-1,  albeit
uch milder and transient [42]. The mechanisms underlying the
evere matrix abnormalities and chondrodysplasia observed in
hese mice (cP4HaIﬂ/−;cP4HaII−/− double mutant mice, combining
eterozygous inactivation of cP4HaI with homozygous inactivation
f cP4HaII) will further help elucidating these important actions in
he growth plate cartilage [5,11,42].
.1.4. HIF-2˛ and the role of hypoxia in articular cartilage andPlease cite this article in press as: C. Maes, Signaling pathwa
sues. Seminars in cell and developmental biology: The biology
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oint pathophysiology
Although HIF-1 and HIF-2 both dimerize with HIF-1  and
hare extensive structural homology (48% homology in overall
mino acid sequence, including some highly conserved important PRESS
ntal Biology xxx (2016) xxx–xxx 5
domains in the proteins), they do not exhibit the same distri-
bution, target genes and functions, and they are consequently
non-redundant. Distinct from HIF-1,  HIF-2 is not critical for joint
speciﬁcation during embryogenesis development or for growth
plate development. Indeed, lack of HIF-2  was found to cause only
a modest and transient delay of endochondral bone development
in several mouse models. Heterozygous mouse embryos (ubiqui-
tously lacking one allele of HIF-2,  i.e. HIF-2+/− fetuses) develop a
mild and transient dwarﬁsm that resolves by the age of two weeks
[43]. Similarly, conditional inactivation of HIF-2  in the limb bud
mesenchyme results in a mild and transient delay in endochon-
dral bone development at E17.5 [44]. The molecular mechanisms
responsible for this phenotype are still largely unknown, but may
involve an impairment of the latest stage of chondrocyte hypertro-
phy in the fetal growth plate. HI plate. HIF-2 was  identiﬁed as an
inducer of the expression of typical proteins made by hypertrophic
chondrocytes that play key roles in endochondral ossiﬁcation, such
as type X collagen, VEGF, and the matrix-degrading enzyme matrix
metalloproteinase (MMP)-13 [43].
In contrast to its limited importance in cartilage during devel-
opment, HIF-2  does appear to play a signiﬁcant role in the
articular cartilage of the postnatal joint and in the pathogenesis
of osteoarthritis (OA). Articular cartilage represents an avascu-
lar, aneural, and alymphatic tissue, which relies for its nutrient
supply and oxygenation on diffusion from the synovial ﬂuid and
the subchondral bone. The limited diffusion capacity of oxygen
has been reported to create a gradient of 6% oxygen at the joint
surface to only 1% in the deeper layers (reviewed in [45]). Artic-
ular chondrocytes consequentially face an hypoxic environment
throughout life, and are very well adapted to these challenging
conditions by the relatively constitutive expression of HIFs [45].
Both HIF-1  and HIF-2  are expressed in human articular sur-
face chondrocytes [29,35,37,46], suggesting that their actions may
contribute to the maintenance of the stable articular chondrocyte
phenotype. However, increased expression of both factors has been
found in human OA cartilage. The mRNA expression of HIF-1 and
its target genes was  elevated and correlated positively with OA
progression and the severity of cartilage degradation [47]. HIF-2
levels were also higher in surgical specimens of OA  patients and
osteoarthritic mice compared with non-diseased cartilage [43,48].
The functioning of the respective HIF  subunits in OA cartilage,
however, appears to differ signiﬁcantly, at least in animal mod-
els. While HIF-1  has been postulated to be protective against OA
and possibly drive compensatory mechanisms to conserve articu-
lar cartilage integrity during OA development, HIF-2  appears to
be a catabolic regulator, mediating osteoarthritic cartilage matrix
breakdown in OA [6]. In line therewith, inhibition of HIF-1 in the
knee joint of normal healthy mice (by intra-articular injection of 2-
methoxyestradiol) led to chondrocyte apoptosis and osteoarthritic
changes, including articular cartilage degeneration and osteophyte
formation [49]. In contrast, HIF-2  haplo-insufﬁciency in Epas1+/−
mice prevented cartilage degradation and osteophyte formation
after surgically induced instability of the knee joint, thus protecting
the mice against OA [43,48]. Another loss-of-function study devel-
oped cartilage-targeting nanoparticles to deliver small-interfering
RNA (siRNA) silencing HIF-2  expression to chondrocytes, which
was associated with a decrease in HIF-2,  catabolic factors and
VEGF in vitro. Upon intra-articular injection of the nanoparticles
into the knee joints of OA-affected mice, cartilage integrity was
maintained and synovial inﬂammation alleviated [50]. Conversely,
gain-of-function of HIF-2, obtained genetically or via adenovirus-
mediated overexpression of the Epas1 gene following local injectionys effecting crosstalk between cartilage and adjacent tis-
 and pathology of cartilage, Semin Cell Dev Biol (2016),
in the mouse knees, induced expression of the catabolic HIF-2
target genes and triggered severe cartilage destruction [48]. The
upstream mechanisms leading to aberrant HIF-2  activity in OA
appear to involve nuclear factor (NF)-B signaling, itself activated
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y mechanical stress and/or proinﬂammatory cytokines, rather
han HIF-2  regulation through PHD activity [43,48,51]. Thus, sev-
ral animal models implied a pathophysiological role for HIF-2
n OA. A role for HIF-2 in human OA was suggested as well, as
 functional single nucleotide polymorphism (SNP) in the human
PAS1 gene encoding HIF-2 was found to associate with knee OA
n a Japanese cohort [43], although this genetic link could not be
ecapitulated in all patient cohorts [52].
The role of hypoxia and HIFs, acting in conjunction with inﬂam-
atory pathways, in rheumatoid arthritis is complex and beyond
he scope of this review; for more information on this subject, see
53].
.2. The central role of angiogenic signaling by VEGF in the
onversion of cartilage to bone
In the previous section, mechanisms were discussed by which
he immature cartilage of the cartilaginous condensations and the
eveloping growth plate sustain as avascular tissues, including dis-
ant actions of VEGF to mediate the growth of the vascular network
n the surrounding tissues, without invading the cartilage proper.
ifferent from immature chondrocytes, however, terminally differ-
ntiated hypertrophic chondrocytes allow and even trigger blood
essels to invade their matrix, a process that is inherently associ-
ted with decay of the hypertrophic cartilage and its replacement
y bone. Throughout the endochondral ossiﬁcation process, three
ey phases can be discriminated where vascular invasion of hyper-
rophic cartilage initiates the conversion of avascular cartilage into
ighly vascularized bone and bone marrow tissue, cumulating in
he formation of the mature long bone. First, the initial invasion
f the cartilage anlagen during embryonic development involves
ndothelial cells and osteoprogenitors co-invading from the peri-
hondrial tissues and organizing the primary center of ossiﬁcation.
econd, continual capillary invasion at the metaphyseal border of
he growth cartilage mediates progressive bone lengthening. Third,
ascularization of the epiphyseal cartilage at the ends of the bone
nitiates the formation of secondary ossiﬁcation centers. The cen-
ral role of hypertrophic cartilage-derived VEGF as inducer of these
onsecutive vascularization and ossiﬁcation events in the expand-
ng bone centers will be brieﬂy reviewed here; for more extensive
eviews see [21,54].
.2.1. VEGF controls the initial osteo-angiogenic invasion of the
ndochondral bone template
Around embryonic day 14 (E14) in the mouse, the chondro-
ytes located in the center (diaphysis) of the cartilage anlagen
ecome hypertrophic and calcify their extracellular matrix. At
his time, cells in the surrounding perichondrium differentiate
nto osteoblasts, at least in part under the inﬂuence of IHH
ignaling from the cartilage (see below), and form a mineral-
zed bone collar, which constitutes the provisional cortical bone
haft. Besides osteogenic cells, also blood vessels and blood-borne
steoclasts increasingly accumulate in the perichondrial region.
ubsequently, they invade the mid-diaphyseal hypertrophic car-
ilage core, degrade the cartilage matrix, and erode the region to
ake room for osteoblasts and bone marrow cells to populate the
ewly forming bone center. The hematopoietic precursors migrate
rom the fetal liver to establish marrow-based hematopoiesis.
As such, the initial vascular invasion of cartilage launches the
ormation of the primary ossiﬁcation center or primitive bone mar-
ow cavity of the long bone. It was shown, by using lineage-tracing
pproaches in mice, that the blood vessel invasion is closely associ-Please cite this article in press as: C. Maes, Signaling pathw
sues. Seminars in cell and developmental biology: The biology
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ted with the migration of perichondrial osterix (Osx)-expressing
steoprogenitors into the nascent bone center, with a subset of the
steoprogenitors co-invading the tissue while positioning as peri-
ytes around the blood vessels [55]. This coupled osteo-angiogenic PRESS
ntal Biology xxx (2016) xxx–xxx
invasion process may  provide a partial explanation for the fact
that cartilage neovascularization is an absolute requirement for the
endochondral replacement of cartilage by bone, as supported by
experiments physically blocking the angiogenic invasion process
[56].
Several mouse models support the notion that VEGF plays crit-
ical roles in the recruitment of perichondrial blood vessels and
the initial angiogenic invasion of the cartilage anlagen, and that
these represent absolutely critical steps in the early development
of the long bones [2,14,25,56–59]. At this time in development,
endothelial cells, osteoblasts, and osteoclasts − the cell types that
accumulate in the perichondrium surrounding the hypertrophic
cartilage and all express VEGF receptors (VEGFRs) (see below) −
coordinately invade the cartilaginous template [21,55] (Fig. 3A).
Hypertrophic chondrocytes produce high levels of VEGF, a feature
that is characteristically embedded in the terminal chondrocyte
differentiation program and that is incompletely understood at
the molecular level at present, although several factors have been
implicated and may  cooperatively regulate the VEGF induction.
These include the transcription factors runt-related transcription
factor 2 (Runx2) and Osx [60–62], which are primarily known for
their essential roles in osteoblast differentiation (see below) but
are also expressed in hypertrophic and pre-hypertrophic chon-
drocytes, respectively. Hypoxia too is a potent inducer of VEGF
expression in chondrocytes, as outlined in the previous section;
yet, it is not fully clear to what degree hypoxia and HIF-1 con-
tribute to the high levels of VEGF production by late hypertrophic
chondrocytes in the pre-invasion bone template and in the growth
plate. One study suggested that Runx2 might be involved in the pro-
tein stabilization of HIF-1 and induction of VEGF in hypertrophic
chondrocytes [63]. Moreover, in vivo observations do underscore
a potential hypoxia- and HIF-1-mediated control mechanism of
the VEGF expression in the pre-invasion cartilage anlagen (Fig. 3A)
[2,3,29]. Indeed, mice lacking either HIF-1  or VEGF in cartilage
showed a delay in the initial invasion and primary ossiﬁcation
center formation, which could be rescued by forced VEGF164 over-
expression in both mutants [2]. Also at this speciﬁc, early stage
in the bone development process, the VEGF164 isoform proved
to be of particular importance, as embryos expressing only the
VEGF120 isoform or only the VEGF188 isoform both showed a
delay in the early vascular invasion and development of the long
bones [14,25]. Conversely, in mice over-expressing VEGF164 in
the endochondral skeleton, achieved by a Col2-Cre-mediated con-
ditional over-expression model, the osteo-angiogenic invasion of
developing bone centers occurred prematurely and excessively,
with aberrant bone deposition in this vascularized area leading
to misshapen limbs [64]. These ﬁndings strongly suggest that
hypoxia-induced, HIF-mediated VEGF expression in cartilage is
required for the recruitment of angiogenic blood vessels into devel-
oping endochondral bone centers (Fig. 3A).
The concomitant recruitment and invasion by osteoclasts and
osteoprogenitors may  be in part explained as well by VEGF’s cell-
autonomous effects on these cell types. VEGF is a homodimeric
glycoprotein of 45 kDa that belongs to the dimeric cysteine-knot
growth factor superfamily. It binds to and activates two tyro-
sine kinase receptors, VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1),
whose prime role is to regulate angiogenesis, both in physiologi-
cal and pathological conditions [20]. However, besides endothelial
cells that are the principal targets of VEGF, numerous other cell
types express VEGF receptors and respond to VEGF signaling
[65,66], including osteoprogenitors, osteoblasts and osteoclasts
[21,58]. Overall, VEGF can promote or modulate chemotaxis, pro-ays effecting crosstalk between cartilage and adjacent tis-
 and pathology of cartilage, Semin Cell Dev Biol (2016),
liferation, differentiation, survival and/or activity of a range of
non-endothelial cell types, including osteoblasts and osteoclasts.
While in most circumstances VEGF functions as a paracrine medi-
ator, autocrine and intracrine roles have been described as well,
ARTICLE IN PRESSG ModelYSCDB-2032; No. of Pages 18
C. Maes / Seminars in Cell & Developmental Biology xxx (2016) xxx–xxx 7
Fig. 3. The role of HIF and VEGF in the neovascularization of cartilage and its conversion to bone. (A) VEGF controls the initial osteo-angiogenic invasion of the endochondral
bone  template. During long bone development, hypertrophic chondrocytes in the middle diaphyseal region of the avascular cartilage template become hypoxic (blue
shading) and express high levels of VEGF. Both HIF-1 and VEGF are required for the timely invasion of the template by blood vessels from the perichondrium. Along with
the  endothelium, osteoprogenitors move into the tissue, start to deposit bone, and establish the primary ossiﬁcation center. Osteoclasts, cells of hematopoietic origin, also
appear  coinciding with vascular accumulation in the perichondrium and co-invade the cartilage. All the cell types involved express VEGF receptors (VEGFR) and can respond
directly  to VEGF signaling by enhanced migration, recruitment, proliferation and/or differentiation. (B) VEGF actions at the chondro-osseous junction and the metaphysis
of  growing long bones. The matrix-binding isoforms of VEGF, VEGF164 and VEGF188, are stored in the cartilage matrix after their secretion by hypertrophic chondrocytes.
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via  the vascular growth) and directly (via VEGFR signaling), VEGF stimulates bone
hereby coordinating the conversion of cartilage into bone at the chondro-osseous 
ncluding in cell types present in the bone environment, such
s hematopoietic stem cells (HSCs) [67], endothelial cells [68],
nd osteoblasts [69]. A cell-autonomous role of VEGF in chondro-
ytes, e.g. contributing to their survival, has also been suggested,
lthough the known signaling receptors VEGFR1 and VEGFR2 are
ot expressed in cartilage [14,15,70].
Thus, besides inducing angiogenesis in the perichondrium, VEGF
ppears to play a broader and synchronizing role in the coordinated
nvasion of the endochondral bone template by directly affecting
he endothelial, osteoclastic, and osteolineage cell types involved
Fig. 3A).
.2.2. Coordinating actions of VEGF at the chondro-osseous
unction and metaphysis of growing long bones
During longitudinal bone growth following the establishment of
he primary ossiﬁcation center, the last row of hypertrophic chon-
rocytes of the growth cartilage at the chondro-osseous junction is
ontinuously replaced with trabecular bone that increasingly ﬁlls
he metaphysis. This progressive turnover of cartilage into bone
s driven by the unceasing capillary invasion of the hypertrophic
hondrocytes by angiogenic growth of vessels from the growing
one and marrow cavity (Fig. 3B). These vessels likely correspond
o the H-type blood vessels recently described to be comprised ofPlease cite this article in press as: C. Maes, Signaling pathwa
sues. Seminars in cell and developmental biology: The biology
http://dx.doi.org/10.1016/j.semcdb.2016.05.007
ndothelial cells that highly express the markers CD31 (PECAM-1)
nd endomucin, and that are interacting particularly strongly with
unx2+ and Osx+ osteoprogenitors and sensitive to changes in oxy-
enation and ageing [71–73]. While these H-type endothelial cellsts blood vessels towards the growth plate and stimulates angiogenesis. Indirectly
ation by osteoblasts and cartilage resorption and bone remodeling by osteoclasts,
ons and stimulating the growth of the long bones. Figure adapted from [21,177].
particularly make up the vasculature in the metaphysis and the
endosteum, the endothelial cells of the sinusoidal vessels in diaph-
ysis express CD31 and endomucin only weakly and are considered
to constitute a distinct type of endothelium (type L) [71–73].
Also here, VEGF provides a major engine to the coordinated
decay and resorption of the hypertrophic cartilage matrix, vascular
expansion and the formation of trabecular bone (Fig. 3B). Inhibi-
tion of VEGF action in juvenile mice, through administration of a
soluble VEGF receptor chimeric protein (sFlt-1), impaired vascular
invasion of the growth plate, and concomitantly, trabecular bone
formation and bone growth were reduced and the hypertrophic
cartilage zone became enlarged, likely as the result of reduced
osteoclast-mediated resorption [74]. Additional mouse genetic
studies exposed the speciﬁc roles of VEGF and its major splice
isoforms [2,14,25,58,64,69]. Altogether, these studies support the
model that VEGF, secreted at high levels by hypertrophic chon-
drocytes, becomes partially sequestered in the cartilage matrix,
particularly the longer VEGF isoforms (VEGF164 and VEGF188)
that have strong matrix-binding afﬁnity. The shorter VEGF iso-
forms (VEGF120 and VEGF164) are largely soluble and diffuse
from the cartilage, attracting blood vessels towards the chondro-
osseous junction and stimulating endothelial cells to form new
blood vessels through angiogenesis. This is indirectly associatedys effecting crosstalk between cartilage and adjacent tis-
 and pathology of cartilage, Semin Cell Dev Biol (2016),
with increased delivery of osteoclast and osteoblast progeni-
tors. The osteoclasts and osteoclast-derived MMP-9 [75,76] can
release more matrix-bound VEGF from the cartilage that is being
resorbed, creating a positive-feedback system. Moreover, VEGF also
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as chemo-attractive activity in stimulating osteoclast invasion
f cartilage, and enhances osteoclast differentiation, survival, and
esorptive activity [76,77]. The osteoblasts on their turn deposit
one on the remnants of the cartilage matrix, in part stimulated
irectly by VEGF signaling, which enhances the recruitment and
ifferentiation of osteoblasts [21,54]. This model reconciles the data
f a large set of mutant mouse models and in vitro studies, which
ltogether identiﬁed VEGF as a crucial physiological driver of the
ndochondral turnover process that progressively transforms car-
ilage into bone at the metaphyseal growth plate during skeletal
rowth.
.2.3. VEGF-induced neovascularization of epiphyseal cartilage
ediates secondary ossiﬁcation center development
Around postnatal day 5 (P5) in mice, the process of secondary
ssiﬁcation center formation is initiated. At the ends of the long
one, islands of hypertrophic chondrocytes appear within the
ound chondrocyte layers of the growth cartilage, located close to
he articular surfaces (see Fig. 2). It is unclear what triggers the
ocal and patchy differentiation of chondrocytes, but the PTHrP-
HH pathway is likely to be involved (see below). As always, the
ransition to hypertrophy is associated with the expression of typ-
cal hypertrophic chondrocyte markers such as collagen type X
nd VEGF. The appearance of the hypertrophic cartilage islands is
losely followed by the formation of invaginations in the cartilage,
he so-called cartilage canals, containing blood vessels and other
ells. These tissue-invading structures subsequently expand and
use to form the secondary center of ossiﬁcation. As a result, true
rowth ‘plates’ comprised of chondrocytes and cartilage matrix
re left in between the metaphyseal and epiphyseal bone centers,
ediating further postnatal bone lengthening until growth ceases
t puberty.
At present, it has not been fully established whether the signals
riggering the invasion of the epiphyseal cartilage by blood ves-
els are coming from the cartilage proper, but it seems likely that
hondrocyte-derived VEGF plays a central role also in this phase of
artilage neovascularization and turnover into bone (Fig. 2). In par-
icular, the soluble isoforms VEGF120 and VEGF164 are required
or epiphyseal vascularization and induction of secondary ossiﬁca-
ion in growing long bones. VEGF188/188 mice (the knock-in model
entioned before, in which the endogenous VEGF gene is replaced
y VEGF188-encoding cDNA, such that the other two major VEGF
soforms VEGF120 and VEGF164 are no longer expressed) showed
trongly reduced vascularity around the growth cartilage, impaired
nvasion of vascular canals into the epiphysis in early postnatal life,
nd drastically impaired formation of the epiphyseal bone center,
ssociated with a severe knee joint dysplasia and dwarﬁsm [14].
Besides VEGF-mediated vascular invasion of cartilage, col-
agenolytic actions by membrane type 1-MMP  (MT1-MMP, also
nown as MMP-14) mediating matrix remodeling and angiogenesis
ave also been implicated in the formation of the secondary ossiﬁ-
ation center [78,79]. Nevertheless, this aspect of the endochondral
ssiﬁcation process remains far from being understood in all its cel-
ular details and regulatory mechanisms. It will be of interest to see
ore work in the future characterizing these events and increasing
ur knowledge of the processes leading to the establishment of the
econdary centers of ossiﬁcation.
. Chondrocyte-driven regulation of osteoblast
ifferentiation in surrounding tissuesPlease cite this article in press as: C. Maes, Signaling pathw
sues. Seminars in cell and developmental biology: The biology
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Endochondral ossiﬁcation during development requires a
ightly orchestrated progression of chondrocyte differentiation and
steoblastogenesis in the adjacent perichondrial tissue. A highly
oordinated molecular crosstalk between the cell types involved PRESS
ntal Biology xxx (2016) xxx–xxx
is responsible for the aligned development of cartilage and bone.
The details of this interplay are only beginning to be unraveled, but
key roles are played by secreted signals such as Indian hedgehog
(IHH), bone morphogenetic proteins (BMPs), and ﬁbroblast growth
factors (FGFs). In addition, the processes of chondrocyte turnover,
osteoblast differentiation, recruitment, and bone-forming activity
in the perichondrium and the developing bone center is coupled to
the vascularization of the bone and inﬂuenced by VEGF signaling as
well as by angiocrine signals emanating from the vasculature (also
see section 4).
3.1. Perichondrial osteoblastogenesis
The ﬁrst osteoblasts differentiating in the developing long bones
appear in the perichondrium. In fact, early perichondrial cells are
thought to be derived from bipotential osteochondroprogenitors,
capable of differentiating into either chondrocytes or osteoblasts. A
transcriptional program directed by the transcription factors Runx2
and Osx, and the transcriptional co-activator -catenin (a key medi-
ator of canonical WNT  signaling) is essential for the commitment
of the mesenchymal precursor cells to the osteoblastic lineage
[80] (see Fig. 4). Committed osteoprogenitors or pre-osteoblasts
can subsequently differentiate further into mature osteoblasts,
increasingly expressing bone matrix proteins including type I col-
lagen (COL1), osteopontin and osteocalcin. The mature osteoblasts
deposit and mineralize a sheath of bone matrix called the bone
collar, which forms the initiation site of the later cortical bone,
around the mid-part of the cartilage model. At least a subset of
perichondrial osteoprogenitors, however, does not differentiate
to mature osteoblasts in the perichondrium. Instead, these cells
remain in the perichondrium as immature osteoprogenitors, until
at least a subset of them co-invades the mid-portion of the car-
tilaginous bone template together with the blood vessels during
the initial formation of the primary ossiﬁcation center, as out-
lined earlier in this review [55]. These perichondrium-derived
osteoprogenitors will populate the nascent primary bone center,
where they either remain as rather undifferentiated stromal cells
or differentiate to bone-forming osteoblasts [55]. The matured
cells deposit mineralized bone matrix on the remnants of calciﬁed
cartilage, thereby generating the primitive trabecular bone inside
the bone shaft. Thus, the perichondrium is considered a primary
source of osteoblasts during endochondral ossiﬁcation [55,56,81].
In addition to perichondrial osteoprogenitors, recent studies pro-
vided evidence that also chondrocytes themselves can contribute
to the osteoblast pool in the metaphysis. Indeed, lineage trac-
ing strategies tracking the fate of chondrocytes, by making use of
cartilage-speciﬁc Cre and CreERt mouse lines driven by the Aggre-
can (Agc1) or COL10a1 gene promoters, indicated that at least a
subset of growth plate chondrocytes can give rise to cells express-
ing osteoblast markers and populating the trabecular bone region
below the chondro-osseous junction, possibly through a process of
trans-differentiation [82,83]. Thus, the ultimate fate of the growth
plate chondrocyte may  not necessarily be to undergo apoptosis at
the end of the hypertrophic differentiation program as most gener-
ally assumed, but further research will be needed to elucidate the
speciﬁcs, the magnitude, and the regulation of the alternative fates
of chondrocytes during endochondral ossiﬁcation.
The early osteoblastogenesis processes in the perichondrium
have been relatively well characterized, particularly through the
generation and investigation of genetically modiﬁed mouse mod-
els, and the importance of the key transcription factors Runx2 and
Osx, and transcriptional co-activator -catenin, is well established.ays effecting crosstalk between cartilage and adjacent tis-
 and pathology of cartilage, Semin Cell Dev Biol (2016),
3.1.1. Runx2
Runx2 (previously known as core-binding factor a1 (Cbfa1)), a
transcription factor of the ancient runt family, is absolutely essen-
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ial for the induction of osteoblast differentiation and endochondral
nd intramembranous bone formation. Runx2-deﬁcient mice lack
steoblasts and do not form bone at all; instead a completely carti-
aginous skeleton develops without any true bone matrix [84,85].
n heterozygous (haploinsufﬁcient) Runx2 mutant mice, the defect
n osteoblast differentiation is limited to intramembranous bones
84]. The resulting phenotype in these mice closely resembles the
leidocranial dysplasia (CCD) syndrome in humans, a dominantly
nherited developmental disorder of bone, in which RUNX2 was
ound to be mutated in most patients [86,87]. Consistent with its
unction as an early transcriptional regulator of osteoblast differ-
ntiation, Runx2 is an early molecular marker of the osteoblast
ineage, being highly expressed in perichondrial mesenchyme and
n all osteoblasts [88,89]. Hypertrophic chondrocytes also express
unx2, and Runx2 plays important roles in cartilage biology [90,91].
Runx2 is both sufﬁcient and essential for differentiation of mes-
nchymal cells into osteoblasts, and it inhibits their differentiation
nto adipocytes and chondrocytes. Runx2 mediates osteoblast dif-
erentiation by inducing alkaline phosphatase (ALP) activity, by
egulating the expression of a variety of bone matrix protein genes,
nd by stimulating mineralization in immature mesenchymal cells
nd osteoblastic cells [88,89]. Furthermore, Runx2 regulates the
xpression of RANKL and OPG in osteoblasts, thus affecting osteo-
last differentiation [92,93].
The DNA-binding sites of Runx2 have been identiﬁed in major
steoblast-speciﬁc genes, including the genes that encode colla-
en type 1, osteopontin, osteonectin, bone sialoprotein, osteocalcin,
nd Runx2 itself, and Runx2 induced the expression of these genes
r activated their promoters in vitro [80]. Runx2 transcriptional
egulation of different stages of osteoblast differentiation is very
omplex and involves interactions with a myriad of transcriptional
ctivators, repressors and other co-regulatory proteins. The current
odel is that Runx2 triggers the expression of major bone matrix
rotein genes and the acquisition of an osteoblastic phenotype at
n early stage of osteoblast differentiation, while inhibiting the late
steoblast maturation stages and the transition into osteocytes. As
uch, Runx2 may  play an important role in maintaining a supply of
mmature osteoblasts [88,89].
.1.2. Osx
Runx2 also regulates the expression of Osx (encoded by the Osx
r Sp7 gene), an SP family transcription factor with three zinc-
nger motifs. Osx is expressed in osteoprogenitors, in osteoblasts,
nd at a lower level in pre-hypertrophic chondrocytes. Simi-
ar to Runx2-deﬁcient mice, mice lacking Osx showed complete
ack of osteoblasts and absence of both intramembranous and
ndochondral bone formation [94]. Thus, Osx represents another
ranscription factor that is essential for osteoblast differentiation.
ecause Runx2 is expressed in the mesenchymal cells of Osx-null
ice but Osx is not expressed in Runx2-null mice, it can be con-
luded that Osx acts downstream of Runx2 [94]. Furthermore, the
sx gene contains a consensus Runx2-binding site in its promoter
egion [95]. The transcriptional activity of Osx involves its inter-
ction with NFATc1, cooperatively forming a complex that binds
o DNA and induces the expression of the COL1a1 gene [96]. Osx
ay  be important for directing precursor cells away from the chon-
rocyte lineage and toward the osteoblast lineage. Expression of
enes characteristic of mature osteoblasts (such as those encod-
ng bone sialoprotein, osteopontin, osteonectin, and osteocalcin)
as absent in cells surrounding chondrocytes in Osx-null mice, and
nstead these cells express genes characteristic of chondrocytes
SOX9, SOX5, COL2a1) [94]. Osx has also been reported to inhibitPlease cite this article in press as: C. Maes, Signaling pathwa
sues. Seminars in cell and developmental biology: The biology
http://dx.doi.org/10.1016/j.semcdb.2016.05.007
hondrogenesis in vitro [97,98]. Overall, it is currently thought that
unx2 has a crucial role in the earliest determination stage of the
steoblast lineage, driving mesenchymal progenitors to become
steoprogenitors, while Osx regulates at a later stage the differen- PRESS
ntal Biology xxx (2016) xxx–xxx 9
tiation of osteoprogenitors to functional, bone-forming osteoblasts
expressing high levels of osteoblast markers.
3.1.3. ˇ-catenin
A third crucial osteoblastogenic factor acting at the transcrip-
tional level is -catenin. -catenin represents a key mediator of
canonical signaling by WNTs, a large family of secreted growth fac-
tors (19 different members in mouse and human genomes) that
play essential roles in multiple developmental processes, adult
tissue maintenance, and cancer [99]. During the past decade, canon-
ical WNT  signaling has been shown to play a signiﬁcant role in the
control of osteoblastogenesis and bone formation [100,101].
WNTs can transduce their signals through several different
downstream signaling pathways, of which the canonical WNT/-
catenin pathway is the best understood [99,102]. Central to this
pathway is the regulation of the protein stability of -catenin.
In the absence of WNTs, cytoplasmic -catenin is constitutively
degraded through its phosphorylation by glycogen synthase kinase
3- (GSK3-) in a large protein complex brought together by AXIN
and adenomatous polyposis coli (APC) [99]. Phosphorylated -
catenin is recognized by a -transducin repeat containing protein
(-TrCP) that targets it for proteasome-mediated degradation. In
the presence of WNT  stimulation, the WNT  ligands bind to two
synergistically acting families of WNT  (co-)receptors: the Friz-
zled (Fz) receptor family members and low-density lipoprotein
receptor-related proteins (LRP5 or LRP6). This interaction results
in an inhibition of -catenin degradation; the -catenin protein
is stabilized, accumulates in the cytoplasm and translocates to
the nucleus. Here, it interacts with members of the T cell fac-
tor/lymphoid enhancer factor (TCF/LEF) family of DNA-binding
transcription factors to regulate the expression of downstream tar-
get genes [99]. Besides its actions as a transcriptional coactivator,
-catenin is also involved in cell–cell adhesion by binding to cad-
herins.
Genetic studies analyzing conditional -catenin loss- and
gain-of-function mouse models provided compelling evidence
that -catenin is a crucial transcription factor determining the
osteoblast lineage commitment of mesenchymal progenitors.
During development, -catenin is indispensible for suppressing
chondrocytic differentiation of bipotent osteochondroprogeni-
tor cells, and for stimulating them to differentiate into mature
osteoblasts [103]. Inactivation of -catenin in mesenchymal pro-
genitor cells blocked osteoblast differentiation, and mesenchymal
cells in the perichondrium and calvarium differentiated into chon-
drocytes instead [104] Hu, 2005 #436;Hill, 2005 #6278;Rodda,
2006 #6292}. Combined deletion of the key WNT  co-receptors Lrp5
and Lrp6 in the embryonic mesenchyme largely recapitulated the
loss of -catenin, the phenotypes being characterized by impaired
osteoblast differentiation in the developing mutant mouse skele-
tons [105]. In postnatal life, deletion of the gene encoding -catenin
in Osx-expressing osteoprogenitors inhibited their differentiation
into mature osteoblasts, and instead induced the expression of
adipocytic markers [106,107]. Inactivating -catenin in more dif-
ferentiated cells of the osteoblast lineage, mature osteoblasts or
osteocytes, resulted in low bone mass phenotypes in mice partic-
ularly by increasing osteoclastogenesis and bone resorption; the
underlying mechanism involved impaired expression of OPG, an
inhibitor of osteoclast formation, in the absence of -catenin in
differentiated osteoblast lineage cells. Thus, -catenin also plays an
important role in the coupling between osteoblast and osteoclast
activity during bone remodeling [108,109].
The initiation of this comprehensive osteoblastogenic transcrip-ys effecting crosstalk between cartilage and adjacent tis-
 and pathology of cartilage, Semin Cell Dev Biol (2016),
tional program in the perichondrium is at least in part directed by
the adjacent chondrocytes in the growth cartilage. One  signal that
plays a key role in the crosstalk between chondrocytes in devel-
oping long bones and osteoblast precursor cells in the surrounding
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erichondrium is the secreted molecule IHH, which is produced by
he pre-hypertrophic chondrocytes and induces Runx2 expression
n adjacent cells as outlined below [110,111].
.2. Actions of IHH in directing osteoblastogenesis during bone
evelopment
IHH, a member of the conserved family of hedgehog pro-
eins, is produced by the pre-hypertrophic and early hypertrophic
hondrocytes. Hedgehog proteins, upon binding to the receptor
atched (PTC), signal through the seven-pass transmembrane pro-
ein Smoothened (SMO) to regulate gene transcription through
oth derepression and activation of the GLI family of transcription
actors [112]. In endochondral bones the PTC receptor (which is also
 downstream target of IHH signaling) is present in chondrocyticPlease cite this article in press as: C. Maes, Signaling pathw
sues. Seminars in cell and developmental biology: The biology
http://dx.doi.org/10.1016/j.semcdb.2016.05.007
nd perichondrial domains adjacent to the domain of IHH pro-
uction, encompassing proliferative chondrocytes, perichondrial
esenchymal cells and osteoblasts. In growth plate chondrocytes,
HH regulates the pace of cellular differentiation via a negative
ig. 4. Actions of IHH in endochondral bone development. IHH, expressed in pre-hyper
he  coordination of chondrocyte proliferation and differentiation, perichondrial osteobl
ifferentiated hypertrophic cartilage. The molecular regulation of the pace of chondroc
ntensely expressed in periarticular chondrocytes close to the end of the bone. Secret
hondrocytes and intensely in pre-hypertrophic chondrocytes, i.e. the chondrocytes in tran
nd  hypertrophic cells. PTHrP-PTHR1 signaling keeps the cells proliferating and delays the
hondrocyte columns and slowing down the generation of cells that can produce IHH. W
lock  on hypertrophic differentiation and become IHH-expressing (pre-)hypertrophic ch
elayed through PTC, present on cells in the regions adjacent to the domain of IHH produ
ther  via a negative feedback signaling pathway that controls the cellular differentiation
f  hypertrophic chondrocyte signals such as VEGF and the initiation of cartilage invasion
lso  directly stimulates chondrocyte proliferation, and converts mesenchymal progenitor
hese  cells. Perichondrial osteoblast differentiation is transcriptionally driven by Runx2, 
o  IHH production, IHH determines the site of bone collar formation. Thus, IHH is a centra PRESS
ntal Biology xxx (2016) xxx–xxx
feedback signaling pathway with parathyroid hormone-related
peptide (PTHrP) acting through the common PTHrP/PTH receptor
(PTHR1), thereby controlling the onset of hypertrophic differenti-
ation [110,111]. In addition, IHH directly stimulates chondrocyte
proliferation [113–115]. These actions of IHH in chondrocytes
proper are discussed in detail elsewhere in this review series on
The Biology and Pathology of Cartilage. Here, we will focus on
a third key role of IHH in endochondral bone development, in
regulating osteoblastogenesis and bone collar formation in the
perichondrium.
3.2.1. IHH induces perichondrial osteoblastogenesis and bone
collar formation
The ﬁrst evidence for this role in vivo came from mice com-
pletely lacking IHH (IHH-/- or IHH null mice). In addition toays effecting crosstalk between cartilage and adjacent tis-
 and pathology of cartilage, Semin Cell Dev Biol (2016),
alterations in the cartilage, IHH-/- mice displayed a striking absence
of osteoblast differentiation in the perichondrium and a total lack of
bone collar formation [113]. In situ hybridization to detect Runx2
mRNA revealed that Runx2 expression in hypertrophic chondro-
trophic and hypertrophic chondrocytes (beige colored region), plays key roles in
ast differentiation and bone collar formation, and vascular invasion of terminally
yte differentiation involves a negative feedback loop with PTHrP, which is most
ed PTHrP acts through its receptor PTHR1, present at low levels in proliferating
sit from the proliferative to the post-proliferative state at the interface of columnar
ir hypertrophic differentiation, thereby ensuring an adequate length of proliferative
hen the distance from the bone end becomes sufﬁciently large, cells escape the
ondrocytes and next, VEGF-secreting hypertrophic chondrocytes. IHH signaling is
ction, and stimulates the expression of PTHrP. Thus, PTHrP and IHH regulate each
 kinetics in the growth plate. IHH thereby indirectly controls also the expression
 by blood vessels and perichondrial osteoprogenitors. Independent of PTHrP, IHH
 cells in the perichondrium into osteoblasts by inducing the expression of Runx2 in
Osx and -catenin; by launching this differentiation program in domains adjacent
l coordinator of endochondral turnover of cartilage into bone.
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ytes was maintained in IHH null skeletal elements, whereas the
ignal was undetectable in the surrounding perichondrium. Expres-
ion of the mature osteoblast marker osteocalcin was also absent
n the IHH-deﬁcient mice, whereas control mice displayed evident
xpression of Runx2 and osteocalcin in the perichondrial bone col-
ar region [113]. Thus, deﬁciency in IHH led to an early arrest in
steoblast lineage cell differentiation.
Interestingly, very elegant experiments using chimeras that
ontained either PTHR1-/- cells or PTHR1-/-;IHH-/- double mutant
ells indicated that ectopic bone collar fragments were formed
djacent to ectopic hypertrophic chondrocytes, but only when they
xpressed IHH [116,117]. In these chimeric embryos, speciﬁcally
he cells lacking PTHR1, which were dispersed among the wild-type
ells throughout the growth plate, escaped the PTHrP-mediated
lock of differentiation and became hypertrophic ectopically. This
as associated with expression of IHH by those cells and with the
ormation of bone collar in the perichondrial tissues adjacent to
he ectopic hypertrophic chondrocytes. In growth plates contain-
ng cells that lacked both PTHR1 and IHH, ectopic hypertrophic
hondrocytes still formed but the ectopic bone collar formation
as absent, indicating that this feature was dependent on IHH
116,117].
A subsequent study analyzed whether IHH signaling is directly
equired for osteoblast differentiation, by targeting the signal trans-
ucer SMO  in genetically modiﬁed mice [118]. By using different
ol2-Cre lines, with varying degrees of efﬁciency and speciﬁcity
or targeting perichondrial cells and/or chondrocytes, it was  shown
hat conditional inactivation of SMO  from perichondrial cells pre-
ented the formation of a normal bone collar. Furthermore, analysis
f chimeric embryos composed of wild-type and SMO-/- cells
evealed that SMO-/- perichondrial cells failed to contribute to
steoblasts in either the bone collar region or the primary spon-
iosa, but generated ectopic chondrocytes instead [118].
Altogether, these experiments convincingly showed that IHH
irects the site of osteoblast differentiation by localized signaling
rom its pre-hypertrophic/hypertrophic chondrocyte site of pro-
uction to the neighboring perichondrium, where IHH-induced
irect actions provide control of osteoblastogenesis and bone col-
ar formation (Fig. 4) [112–114,116,118–120]. Of note, osteoblast
ifferentiation does not seem to require IHH in all settings to the
ame extent. For instance, while IHH−/− mice showed complete
ack of bone in the endochondral skeleton, intramembranous ossi-
cation in the bones of the skull appeared much less affected by
he absence of IHH [113], although IHH does serve as a positive
egulator of osteoblast differentiation in intramembranous bones
oo [121]. Also, in a conditional knockout model (Prx1-Cre-driven
nactivation of IHH in the limbs) that allowed survival of the mice to
 weeks of age, it was found that although bone formation was  ini-
ially delayed, osteoblast differentiation and bone formation could
ccur in IHH deﬁcient bones postnatally [122].
.2.2. Mechanism of action of IHH in the perichondrium and
ownstream signaling
As mentioned, perichondrial cells are thought to be bipotential
steo-chondroprogenitors; Runx2, Osx, and canonical, -catenin-
ediated WNT  signaling are essential for the commitment of the
esenchymal precursor cells to the osteoblastic lineage [80]. Evi-
ence has shown that the early perichondrial progenitors are
riven into the osteoblast lineage under the inﬂuence of IHH stim-
lating the expression of Runx2 [113,118,123]. In the absence of
HH, cells of the osteoblast lineage fail to activate the expression of
unx2. Yet, forced expression of Runx2 in the skeletal cells (using aPlease cite this article in press as: C. Maes, Signaling pathwa
sues. Seminars in cell and developmental biology: The biology
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ol2-Cre mouse strain that targets both chondrocyte and osteoblast
ineages in the endochondral skeleton to activate a conditional
unx2 transgene engineered into the Rosa26 locus) restored bone
ormation in Runx2–/– embryos, but not in IHH–/– embryos [123]. PRESS
ntal Biology xxx (2016) xxx–xxx 11
Thus, the mechanism through which IHH induces osteoblast dif-
ferentiation appears to require other, yet unidentiﬁed, effectors
in addition to Runx2. Both the WNT/-catenin signaling pathway
and the BMP  pathway have been reported to act downstream of
IHH in regulating osteoblast differentiation from perichondrial cells
during endochondral ossiﬁcation [124,125].
The transcriptional upregulation of Runx2 by chondrocyte-
derived IHH seems to be mediated particularly by GLI2, one of
the GLI family proteins that constitute the downstream transcrip-
tional regulators transducing IHH signals [126]. IHH, like the other
hedgehog proteins encoded by the mammalian genome (namely
Sonic hedgehog (Shh) and desert hedgehog (Dhh)), signals through
a receptor complex consisting of the hedgehog cell surface receptor
PTC and SMO, a putative G-protein-coupled seven trans-membrane
domain protein. In the absence of ligand, PTC represses the activ-
ity of SMO; when a hedgehog protein binds to PTC, the inhibition
of SMO  by PTC is released. SMO  undergoes a conformational
change, activating signaling activity through both derepression and
activation of GLI family proteins. The GLI family transcriptional
regulators, consisting of three related transcription factors termed
GLI1, GLI2, and GLI3 in mammals, represent the key intracellular
transducers of IHH signaling by translocating to the nucleus to
control the transcription of the IHH target genes [127]. GLI3 and
to a lesser extent GLI2 can be proteolytically processed into short
repressor proteins [128,129].
Skeletal abnormalities have been described in mutant mice
lacking the GLI proteins [112]. GLI3 seems to mainly act as a
strong repressor of IHH signals in chondrocytes. Loss of GLI3 causes
severe polydactyly in mice [130], but in IHH-/- mutants it restored
the chondrocyte proliferation defect and delays the accelerated
onset of hypertrophic differentiation [131,132]. Furthermore, the
expression of the IHH target genes PTC and PTHrP was  reacti-
vated in IHH–/–;GLI3–/– mutants [132]. Thus, de-repression of
the GLI3 repressor is thought to be the predominant downstream
mechanism by which IHH controls chondrocyte proliferation and
maturation.
In contrast, GLI2 seems to act predominantly as an activator by
inducing the expression of IHH target genes in skeletal tissues [133].
GLI2 mutant mice exhibit skeletal abnormalities including short
limbs with delayed endochondral ossiﬁcation [134,135]. Upon IHH
signaling, processing of GLI2 is inhibited and the full-length protein
functions as an activator of transcription. GLI2 mediates IHH-
induced osteoblast differentiation in mesenchymal cell lines by
associating with Runx2 and stimulating its expression and func-
tion [126], as well as by inducing BMP2 expression [136]. Moreover,
GLI2 activator alone was found to be sufﬁcient in vivo to induce
vascularization of the hypertrophic cartilage in IHH null mice, but
required simultaneous removal of GLI3 to restore osteoblast differ-
entiation [133,137].
GLI1 seems largely functionally redundant with its close rel-
atives, as GLI1-/- mice do not show any gross abnormalities in
adulthood. Yet, bone formation was impaired in GLI1-/- fetuses
compared with wild-type fetuses and GLI1 seems to participate
in the osteogenic response of perichondrial cells to IHH [138,139].
Other downstream regulators of hedgehog signaling that could
affect GLI actions are suppressor of fused (Sufu) and Kif7, both of
which are also expressed by growth plate chondrocytes [140,141].
3.2.3. Regulation of IHH expression
In the growth plate chondrocytes, the expression of IHH itself is
regulated by Runx2 [142–144], which is also expressed in chondro-
cytes in an IHH-independent fashion [113]. Constitutive expressionys effecting crosstalk between cartilage and adjacent tis-
 and pathology of cartilage, Semin Cell Dev Biol (2016),
of Runx2 in non-hypertrophic chondrocytes induced hypertrophic
differentiation, IHH expression and endochondral bone formation
[143]. Another transcription factor that was found to regulate IHH
expression in chondrocytes is ATF4. In vitro assays indicated that
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TF4 can bind to the IHH promoter and act as a transcriptional
ctivator of IHH in chondrocytes [145]. Ablation of ATF4 in mice
ed to severe skeletal defects, including a short stature and short
imbs with accelerated hypertrophy of chondrocytes and delayed
ssiﬁcation; these abnormalities were associated with reduced IHH
xpression and signaling [145,146]. When ATF4 was overexpressed
electively in chondrocytes of ATF4-/- mice, the reduced stature,
he growth plate defects, and the decrease in IHH expression were
ll corrected. Surprisingly, chondrocyte-derived ATF4 also restored
he osteoblastic phenotype and osteogenesis defects of ATF4-/-
ice, which appeared to be mediated through IHH [146]. In recent
ork the transcription factor core binding factor beta (Cbf) was
lso found to regulate IHH expression [147].
Several secreted signaling molecules regulate the production of
HH, including PTHrP and members of the BMP  and FGF families
see below). VEGF has also been suggested to affect the expression
f IHH [58]. Additional inﬂuences on IHH signaling may  be provided
y the matrix; for instance, IHH may  bind to aggrecan, via chon-
roitin sulphate side chains, and sulphation of these side chains
ppears to be required for normal IHH signaling in the murine
rowth plate [148]. Lastly, for correct IHH signaling also an intact
rimary cilium has to be present [149].
.3. Coupling of chondrogenesis, osteogenesis and angiogenesis in
ndochondral bones
From all the above, it is evident that IHH is a master
egulator of endochondral bone development, coordinating the
emporal-spatial coupling of chondrocyte proliferation, chondro-
yte maturation and osteoblast differentiation in the immediate
djacent perichondrium [127]. Furthermore, IHH functions to syn-
hronize these processes to the vascularization of the endochondral
ones, a prerequisite for subsequent bone formation as outlined
arlier in this review [21]. Indeed, IHH null mice also displayed
 block of vascular invasion of the developing bone template and
rimary ossiﬁcation center formation did not occur by the time
f their death just after birth [113,150]. This phenomenon cannot
e explained by potential consequences of IHH deﬁciency in the
ndothelial cells proper, as the same phenotype was  observed in
ice with conditional inactivation of IHH in Col2-Cre-expressing
ells only [151]. Thus, chondrocyte-derived IHH appears to be
ssential in mediating the invasion of the cartilaginous bone model
y blood vessels, which itself is an absolute requirement for endo-
hondral bone formation and growth to proceed.
Two aspects appear absolutely essential for the initiation of car-
ilage neovascularization in early skeletogenesis, both of which are
nder the control of IHH (Fig. 4). First, as outlined earlier in this
eview, cartilage neovascularization is driven by and dependent
n high levels of VEGF production by hypertrophic chondrocytes
21]. Since IHH determines the timing of terminal differentiation of
hondrocytes to become hypertrophic chondrocytes, it indirectly
etermines the expression of VEGF. However, although chondro-
yte differentiation was delayed at early stages in the IHH mutant
ouse models, at later stages hypertrophic chondrocytes were
resent and found to express markers of terminal differentiation,
ncluding matrix metalloproteinase (MMP)-13, osteopontin, as well
s VEGF [150,151]. Thus, IHH-/- cartilage can produce the angio-
enic signals that are necessary for neovascularization, indicating
hat additional reasons likely underlie the drastically impaired
ascular invasion of IHH-deﬁcient cartilage. This second require-
ent for rendering cartilage permissive for vascular invasion could
e perichondrial osteoblastogenesis and bone collar deposition.Please cite this article in press as: C. Maes, Signaling pathw
sues. Seminars in cell and developmental biology: The biology
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steoblast differentiation and bone collar formation were lack-
ng in IHH-/- mice; concomitantly, the cartilaginous rudiment
emained non-invaded [113,150]. Conversely, in chimera exper-
ments in which IHH was genetically misexpressed in cartilage PRESS
ntal Biology xxx (2016) xxx–xxx
and ectopic bone collar fragments formed near sites of ectopic
IHH production (see before), this was associated with ectopic
vascular invasion at multiple sites along the immature cartilage
[112,116]. The need for perichondrial osteogenesis prior to vascu-
lar invasion is also supported by other studies. For instance, ex vivo
cultured bone explants from which the perichondrium had been
removed, were no longer able to develop a primary ossiﬁcation
center [56]. Runx2-/- mice, Osx-/- mice, and -catenin conditional
knockout mice, all show a block in perichondrial osteoblastogenesis
[84,85,104,152,153], and concomitantly display a near-complete
absence of vascular invasion and primary ossiﬁcation. It remains
however difﬁcult to discern the speciﬁc role of correct bone collar
establishment, given for instance that these osteoblastogenic fac-
tors function in chondrocytes as well and transcriptionally regulate
VEGF [62,154].
Thus, while it is not fully clear as yet what constitutes the initial
trigger that launches the neovascularization of developing bones,
genetic studies in mice have begun to shed light on the intertwined
molecular regulation of chondrocyte differentiation, perichondrial
osteoblastogenesis, and vascular invasion of the cartilage anlagen,
with central roles in the crosstalk between the cartilage and the
adjacent tissues being played by the secreted signals IHH and VEGF.
4. Osteocrine and angiocrine signaling regulating
chondrocyte differentiation and turnover
Besides signals produced by chondrocytes affecting angiogen-
esis and osteogenesis in the surrounding perichondrial tissues
as illustrated above, it is most conceivable that the tight coor-
dination of the developmental cascade in endochondral bones
is reliant on a reverse signaling towards chondrocytes as well
(Fig. 1). Here, we  will brieﬂy touch on some of the signals pro-
duced by mesenchymal progenitors and/or osteoblast lineage cells
in the perichondrium (osteocrine signals) and by endothelial cells
(angiocrine signals), which may  inﬂuence chondrocyte differen-
tiation and turnover/fate. Our knowledge on this bidirectional
crosstalk is, however, still fragmentary and incomplete.
4.1. Crosstalk between the osteogenic perichondrium and the
growth plate
Reciprocal signaling by perichondrial cells to control the car-
tilage mold is thought to occur via the secretion of signaling
molecules that regulate chondrocyte proliferation and differenti-
ation, such as PTHrP, WNTs, BMPs, and FGFs (particularly FGF18)
[111]. As the PTHrP/IHH negative feedback loop is central to the reg-
ulation of chondrocyte proliferation and the pace of chondrocyte
differentiation, it is not surprising that several of these secreted
molecules may  affect the maturation of growth plate chondro-
cytes by inﬂuencing the production of IHH and interacting with
the PTHrP/IHH pathway [155–157]. In fact, each of these path-
ways has multiple mechanisms for interacting with each other and
coordinately regulate chondrocyte proliferation, IHH production,
and terminal hypertrophic differentiation. As indicated in Fig. 5,
perichondrial cells, chondrocytes, and osteoblasts express multiple
BMPs, BMP  receptors, and the BMP  antagonists noggin and chordin,
as well as FGF18 and FGF receptors [158]. Generally, the FGF  and
BMP  pathways appear to antagonize each other during chondrocyte
differentiation [159] (Fig. 5).
4.1.1. BMPsays effecting crosstalk between cartilage and adjacent tis-
 and pathology of cartilage, Semin Cell Dev Biol (2016),
BMPs, secreted proteins belonging to the TGF superfamily,
transduce signals through their serine/threonine kinase receptors
(homomeric or heteromeric complexes composed of type I and
type II BMP  receptor subtypes), which leads to the activation of
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Fig. 5. BMP  and FGF family members in the crosstalk between cartilage and surrounding perichondrial tissues. Several BMP  and FGF family members (ligands, receptors,
antagonists) are expressed in speciﬁc domains of the growth cartilage (depicted from the periarticular end of the epiphysis (top) towards the metaphysis (bottom) as zones
of  immature round chondrocytes, strongly proliferating columnar chondrocytes, pre-hypertrophic and hypertrophic chondrocytes) and in the surrounding perichondrial
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s  indicated in the scheme. Figure modiﬁed from [158].
ntracellular proteins of the Smad family that relay the BMP  sig-
al to target genes in the nucleus [88,160]. Around 20 BMP  family
embers have been identiﬁed to date. Several of the various BMP
igands, BMP  receptors, and BMP  antagonists are expressed in
peciﬁc layers of the growth plate, in the perichondrium, and in
steoblasts [158]. Studies using genetically altered mouse mod-
ls showed that BMP  signaling through type I receptors in growth
late chondrocytes stimulates chondrocyte proliferation and sur-
ival, while concomitantly delaying the conversion to terminal
ypertrophic differentiation [159] (Fig. 5), ﬁndings that conﬁrmed
revious results obtained in limb cultures [155–157]. Of note, in
eveloping bones BMPs are particularly important in the very early
tages of limb patterning and skeletal morphogenesis, when they
lay roles in determining the size and shape of the mesenchy-
al  condensations and in converting the condensing mesenchyme
nto chondrocytes [161–163]. But BMPs also function in the sub-
equent processes of chondrogenesis and osteogenesis and later in
ife during repair of bone defects [164]. The precise roles of BMPs
n these processes have, however, been difﬁcult to establish, given
hat genetic modiﬁcation of BMP  signaling is often associated with
evere early defects and lethality (as for instance seen with loss
f BMP2 or BMP4), potential functional redundancy among family
embers (around 20 BMP  family members have already been iden-
iﬁed), and difﬁculties to discern whether effects on bone formation
ay  be direct versus consequential to alterations in chondrogene-
is [164,165]. Ongoing studies employing conditional (site-speciﬁc
nd/or inducible) mutagenesis strategies will undoubtedly be very
nformative.
.1.2. FGFsPlease cite this article in press as: C. Maes, Signaling pathwa
sues. Seminars in cell and developmental biology: The biology
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The FGF pathway similarly involves multiple ligands and recep-
ors that take part in regulating skeletal development, with most
otable functions in regulating chondrogenesis assigned to the lig-
nds FGF18 and FGF9 and the receptor FGFR3 that they activateood at present, but overall the BMPs and FGFs are thought to modulate chondrocyte
H), and terminal hypertrophic differentiation, in ways that are largely antagonistic
[166–169]. Activating mutations in the human FGFR3 gene cause
dominantly inherited dwarﬁng chondrodystrophies, which is due
to impaired chondrocyte proliferation [170]. FGFR3 is expressed
on proliferating chondrocytes and provides a master block on chon-
drocyte proliferation, through FGFR3-mediated activation of STAT1
activating the cell cycle inhibitor p21Waf1/Cip1 [171]. Accordingly,
FGFR3 inactivation in mice increased chondrocyte proliferation and
prolonged growth [172,173]. These ﬁndings were surprising given
that FGFs are classically viewed as potent mitogens. The effects of
FGF signaling on the differentiation of chondrocytes are less clear.
In vitro, FGF signaling accelerated the late steps of chondrocyte
hypertrophy [155], but mutant mouse models strongly suggested
that FGFR3 signaling in vivo inhibits hypertrophic differentiation
of chondrocytes [170,174,175]. Part of the complexity may arise
from the fact that the effects of FGFR3 are regulated only in part
by direct signaling in chondrocytes, and in part indirectly by FGFs
modulating the expression of the IHH/PTHrP/BMP signaling path-
ways. For instance, mice harboring an activating mutation in FGFR3
have decreased expression of IHH, PTC, and BMP4, whereas the
expression of these genes is upregulated in mice lacking FGFR3
[174,176].
4.2. Angiocrine signaling by skeletal endothelial cells
Invasion of cartilage by blood vessels is inherently associated
with turnover of cartilage into bone. Already several decades ago,
it has been suggested that the invading endothelial cells may elicit
signals that induce apoptosis of chondrocytes; these have, however,
remained unidentiﬁed to date. Currently, the debate is still ongoing
to what extent terminal hypertrophic chondrocytes are destined toys effecting crosstalk between cartilage and adjacent tis-
 and pathology of cartilage, Semin Cell Dev Biol (2016),
undergo apoptosis versus transdifferentiating to osteogenic cells. In
either case, it is highly conceivable that hypertrophic chondrocytes
are exposed to angiocrine signals, expressed and/or released by the
angiogenic endothelial cells at the initial invasion front in the fetal
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one template and at the chondro-osseous junction of the later
rowth plate. In addition to the inﬂuences of oxygenation, nutrient
vailability, endocrine factors and osteoblast and osteoclast pre-
ursors brought to the invasion region by the vasculature, such
ngiocrine signals, albeit as yet unidentiﬁed, may  possibly affect the
ate of the chondrocytes and contribute to the turnover of cartilage
nto bone.
In support of the role of angiocrine signaling in the skeleton,
ecent work implicated Notch-signaling in endothelial cells in the
egulation of endothelial production of Noggin, a major modula-
or of the BMP  pathway, thereby contributing to the control of
ngiogenic-osteogenic coupling [72]. This study employed mouse
odels with endothelium-speciﬁc and inducible inactivation of
arget genes by using Cdh5(PAC)-CreERt2 mice [72]. An intense
olecular cross-talk between endothelial and osteogenic cells
ikely determines the close association between the processes of
one formation and vascularization of the ossiﬁed tissue (see Fig. 1).
esides noggin, several other locally produced angiocrine signals,
ecreted by vascular endothelial cells in the bone microenviron-
ent, may  inﬂuence osteoblast lineage cells and bone formation.
Thus, it may  be anticipated that the currently underappreci-
ted role of angiocrine signaling in the skeleton will be resolved
n the coming years through the use of creative combinations of
ite-speciﬁc and temporally regulated mutagenesis approaches in
ice. This will help to further clarify the molecular underpinnings
f the coupling between cartilage neovascularization and cartilage
urnover, as well as between angiogenesis and osteogenesis, in
one development, homeostasis and fracture healing.
. Summary
A large number of studies performed over the past 20 years
ave established central roles of interacting signaling pathways
nd molecules in the control of chondrocyte development and the
patiotemporal alignment of hypertrophic chondrocyte maturation
ith perichondrial osteoblastogenesis and cartilage neovascular-
zation. Chondrocytes direct osteogenesis and angiogenesis in the
urrounding tissues to a great extent through their production of
HH and VEGF, and we have come a long way already in elucidat-
ng the regulation of their expression, the downstream mechanisms
hat mediate their effects, and the interactions with other signaling
etworks. It does remain challenging to dissect the causative and
onsequential changes associated with genetic mutations in mice
hen studying the complex process of endochondral bone devel-
pment, particularly because a variety of cell types are involved,
hich can be affected both in cell-autonomous and secondary
ays, and because several interconnected processes take place
n a small window of time within the area of the developing
one. Further studies will help to shed full light on these inter-
wined processes and their molecular control, helped by advanced
trategies for target population-selective and temporally controlled
utagenesis in mice. Expanding this toolbox further will be par-
icularly important for the future unraveling of the reciprocal
ignaling events, meaning the communication factors that are
licited by perichondrial mesenchymal progenitors and osteogenic
ells (osteocrine signals) and by endothelial cells (angiocrine sig-
als), and that likely function in the synchronization of cartilage and
one development. As described, our knowledge on the molecular
onstituents of this bidirectional crosstalk is likely still fragmen-Please cite this article in press as: C. Maes, Signaling pathw
sues. Seminars in cell and developmental biology: The biology
http://dx.doi.org/10.1016/j.semcdb.2016.05.007
ary and incomplete, with much remaining to be learned about the
nterplay between skeletal progenitors, chondrocytes, endothelial
ells, osteoblasts, osteoclasts, and other cell types present in the
one environment. PRESS
ntal Biology xxx (2016) xxx–xxx
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